Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 13, 2025

October 13, 2025

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

GlobeNewswire

October 13, 2025

Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight

GlobeNewswire

October 13, 2025

Remix Therapeutics to Present Phase 1 Data of REM-422 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Conference in Late-Breaking Oral Presentation

GlobeNewswire

October 13, 2025

Avacta to Present First Dual Payload pre|CISION® Medicines Data at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets Symposium

GlobeNewswire

October 13, 2025

Press release: Transparency Notification from Shareholder

GlobeNewswire

October 13, 2025

Merus kondigt de selectie aan van het abstract: Petosemtamab in Metastatic Colorectal Cancer (petosemtamab in gemetastaseerde colorectale kanker) voor mondelinge presentatie in de plenaire sessie op de AACR-NCI-EORTC International Conference on…

GlobeNewswire

October 13, 2025

Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 13, 2025

Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 13, 2025

EarlyHealth Group übernimmt CYB3R, das am schnellsten wachsende Cybersicherheitsunternehmen am Golf

GlobeNewswire

October 13, 2025

EarlyHealth Group adquiere CYB3R, la empresa de ciberseguridad de más rápido crecimiento del Golfo

GlobeNewswire

October 13, 2025

EarlyHealth Group רכשה את CYB3R, חברת אבטחת הסייבר הצומחת ביותר באזור המפרץ הערבי

GlobeNewswire

October 13, 2025

EarlyHealth Group acquiert CYB3R, l’entreprise de cybersécurité à la croissance la plus rapide du Golfe

GlobeNewswire

October 13, 2025

EarlyHealth Group Mengakuisisi CYB3R, Perusahaan Keamanan Siber dengan Pertumbuhan Paling Cepat di Wilayah Teluk

GlobeNewswire

October 13, 2025

アーリーヘルス・グループ、湾岸地域で最も急成長しているサイバーセキュリティ企業CYB3Rを買収

GlobeNewswire

October 13, 2025

얼리헬스 그룹(EarlyHealth Group), 걸프 지역 급성장 사이버보안 기업 ‘CYB3R’ 인수

GlobeNewswire

October 13, 2025

EarlyHealth Group Mengambil Alih CYB3R, Firma Keselamatan Siber yang Paling Pesat Berkembang di Teluk

GlobeNewswire

October 13, 2025

EarlyHealth Group收购海湾地区增长最快的网络安全公司CYB3R

GlobeNewswire

October 13, 2025

EarlyHealth Group adquire a CYB3R, empresa de segurança cibernética de crescimento mais rápido do Golfo

GlobeNewswire

October 13, 2025

EarlyHealth Group เข้าซื้อกิจการ CYB3R…

GlobeNewswire

October 13, 2025

EarlyHealth Group 收購海灣地區增長最迅速的網絡安全公司 CYB3R

GlobeNewswire